Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2982320 | The Journal of Thoracic and Cardiovascular Surgery | 2012 | 15 Pages |
Abstract
Contrary to the findings of post hoc analyses of randomized trials, observational studies showed that recent exposure to clopidogrel before coronary artery bypass grafting is associated with increased risk of postoperative death, reoperations for bleeding, blood loss, and need of blood transfusions.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fausto MD, PhD, K. E. Juhani MD, PhD, Gregory Y.H. MD, PhD,